503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
7.12%
Some net income increase while ORCL is negative at -6.82%. John Neff would see a short-term edge over the struggling competitor.
28.02%
D&A growth well above ORCL's 3.47%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-93.78%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-3.53%
Negative yoy SBC while ORCL is 2.48%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
117.68%
Well above ORCL's 129.75% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
58.83%
AR growth is negative or stable vs. ORCL's 137.57%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
-92.69%
Negative yoy inventory while ORCL is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
23.07%
Lower AP growth vs. ORCL's 183.33%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
145.18%
Growth well above ORCL's 97.37%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-130.53%
Negative yoy while ORCL is 106.26%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
66.18%
Operating cash flow growth below 50% of ORCL's 354.98%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-5.95%
Both yoy lines negative, with ORCL at -47.66%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
30.18%
Acquisition growth of 30.18% while ORCL is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-118.24%
Both yoy lines negative, with ORCL at -27.04%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
72.03%
We have some liquidation growth while ORCL is negative at -74.19%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
3875.00%
Growth of 3875.00% while ORCL is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
9.91%
We have mild expansions while ORCL is negative at -57.76%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
113.28%
Stock issuance far above ORCL's 66.41%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
4.11%
Buyback growth below 50% of ORCL's 22.84%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.